Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression.

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2597

Title:	Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression.
Authors:	GEUSENS, Piet Landewe, R Dunstan, C Gaenero, P van der Linden, S Boers, M
Issue Date:	2002
Publisher:	WILEY-LISS
Source:	ARTHRITIS AND RHEUMATISM, 46(9). p. S388-S388
Notes:	Limburgs Univ Ctr, Diepenbeek, Belgium. Univ Hosp, Maastricht, Netherlands. Amgen Inc, Thousand Oaks, CA USA. INSERM, F-69008 Lyon, France. VU Univ Hosp, Amsterdam, Netherlands.
Document URI:	http://hdl.handle.net/1942/2597
ISSN:	0004-3591
ISI #:	000178421801036
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

24

checked on Nov 7, 2023

Check